Global guideline clinical applicability evaluation tool: a systematic review_Chinese Journal of Evidence-Based Medicine

Authors：

LIN Mao ^1,2,3 , ZENG Linan ^1,2 , LI Jialian ^1,2,3 , ZHANG Chuan ^1,2 , HUANG Liang ^1,2,3 , YANG Chunsong ^1,2 , LI Hailong ^1,2 , YI Qiusha ^1,2,4 , KANG Deying ⁵ , LIU Guanjian ⁵ , ZHAO Rongsheng ^6,7 , ZHANG Junhua ⁸ , LI Youping ⁵ , LIU Hanmin ^2,9 ,  WANG Qiang ¹⁰ ,  ZHANG Lingli ^1,2,7

1. Department of Pharmacy/Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University, Chengdu 610041, P.R.China;
2. Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu 610041, P.R.China;
3. West China School of Pharmacy, Sichuan University, Chengdu 610041, P.R.China;
4. West China School of Medicine, Sichuan University, Chengdu 610041, P.R.China;
5. Chinese Evidence-Based Medicine Center, West China Hospital, Sichuan University, Chengdu 610041, P.R.China;
6. Department of Pharmacy, Peking University Third Hospital, Beijing 100191, P.R.China;
7. Evidence-based Pharmacy Committee, Chinese Pharmaceutical Association, Beijing 100044, P.R.China;
8. Centre for Evidence-Based Medicine, Tianjin University of TCM, Tianjin 301617, P.R.China;
9. Department of Pediatrics, West China Second University Hospital, Sichuan Universicy, Chengdu 610041, P.R.China;
10. Medical Management Service Guidance Center, National Health Commission of the People’s Republic of China, Beijing 100044, P.R.China;

Corresponding author：

WANG Qiang, Email: jason2019@sina.cn; ZHANG Lingli, Email: zhanglingli@scu.edu.cn

Keywords：

Guideline; Clinical applicability; Evaluation tool; Systematic review

DOI：

10.7507/1672-2531.201904132

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objectives To investigate the current status of the clinical applicability evaluation tools, and to provide some foundation for establishment of the clinical applicability evaluation index system.Methods 7 databases, 6 guideline databases and 16 academic institutions and the administrative department of health website were systematically searched from inception to April 2019. Two reviewers independently screened literature, extracted data and then included the literature related to the applicability of clinical guidelines. The CPG clinical applicability evaluation index was initially prepared through the subject comprehensive method.Results A total of 19 articles were finally included. Among them, there were 4 evaluation tools for the clinical applicability of the guidelines, and 15 evaluation tools for the guideline clinical applicability evaluation items. Through combing and comparison, we found that these tools had differences in evaluators, evaluation fields and items.Conclusions The global guidelines for clinical applicability assessment tools have different kinds of problems, such as that the tools are not targeted, the indicators are not well-formed, and the methodological knowledge requirement of the evaluators is high. There is still a lack of guidelines for clinical applicability assessment tools from target users’ view.

Citation： LIN Mao, ZENG Linan, LI Jialian, ZHANG Chuan, HUANG Liang, YANG Chunsong, LI Hailong, YI Qiusha, KANG Deying, LIU Guanjian, ZHAO Rongsheng, ZHANG Junhua, LI Youping, LIU Hanmin, WANG Qiang, ZHANG Lingli. Global guideline clinical applicability evaluation tool: a systematic review. Chinese Journal of Evidence-Based Medicine, 2020, 20(4): 437-443. doi: 10.7507/1672-2531.201904132 Copy

1.	The ADAPTE collaboration. The apapte process: resource toolkit for guideline adaptation, version 2.0. Available from: http://www.g-i-n.net/working-groups/adaptation.
2.	曾力楠, 李幼平, 张伶俐, 等. 国内外制订临床指南的指南的循证评价. 中国循证医学杂志, 2016, 16(11): 1322-1330.
3.	Shiffman RN, Dixon J, Brandt C, et al. The guideline implementability appraisal (GLIA): development of an instrument to identify obstacles to guideline implementation. BMC Med Inform Decis Mak, 2005, 5(1): 23.
4.	Gagliardi AR, Brouwers MC, Palda VA, et al. How can we improve guideline use? A conceptual framework of implementability. Implement Sci, 2011, 6(1): 26.
5.	中华中医药学会. 中医临床诊疗指南的临床应用评价指标体系(2012). Available from: http://www.doc88.com/p-3933713266369.html.
6.	李慧, 谢秀丽, 王洋洋, 等. 中医(中西医结合)临床实践指南制修订方法—实施与评价. 中华中医药杂志, 2016, 31(12): 5119-5123.
7.	International Diabetes Federation (IDF) Clinical Guideline Task Force. Guide for guidelines: a guide for clinical guideline development. International Diabetes Federation, 2003. Available at: www.idf.org.
8.	Agree Collaboration. Appraisal of guidelines for research and evaluation in Europe Ⅱ (AGREE Ⅱ) instrument. Available from: http://www.agreetrust.org/.
9.	World Health Organization. WHO handbook for guideline development. Available from: http://www.who.int/about/licensing/copyright_form/en/index.htmluk.
10.	ACCP Evidence-Based Guideline Development. A successful and transparent approach addressing conflict of interest, funding, and patient-centered recommendations. Available from: http://journal.publications.chestnet.org/.
11.	American College of Cardiology Foundation and American Heart Association (ACCF/AHA). Methodology manual and policies from the ACCF/AHA Task Force on Practice Guidelines. American College of Cardiology Foundation and American Heart Association Inc, 2010: 1-88.
12.	Palda V A, Davis D, Goldman J. A guide to the Canadian medical association handbook on clinical practice guidelines. CAN MED ASSOC J, 2007, 177(10): 1221-1226.
13.	BNSc for the Canadian Guideline Adaptation Study Group. Can-implement-guideline adaptation and implementation planning resource, 2012. Available from: http://www.cancerview.ca..
14.	National Institute for Health and Care Excellence (NICE). The guidelines manual. National Institute for Health and Care Excellence, 2012.
15.	Scottish Intercollegiate Guidelines Network (SIGN). SIGN 50: a guideline developer’s handbook. Available from: http://www.sign.ac.uk.
16.	Schunemann HJ, Fretheim A, Oxman AD. Improving the use of research evidence in guideline development I. Guidelines for guidelines. Health Res Policy Syst, 2006, 4(13): 1-6.
17.	European Region of the World Confederation for Physical Therapy. Framework for clinical guideline development in physiotherapy, 2004. Available from: http://www.guidelines-registry.cn/uploadfile/2016/0914/20160914032822587.pdf.
18.	New Zealand Guideline Group. Handbook for the preparation of explicit evidence-based clinical practice guidelines. Available from: http://www.nzgg.org.nz/.
19.	National Health and Medical Research Council (NHMRC). A guide to the development, implementation and evaluation of clinical practice guidelines. Available from: http://www.ausinfo.gov.au/general/gen_hottobuy.htm.
20.	王吉耀, 王小钦, 金雪娟, 等. 中国临床实践指南评价体系的制定与初步验证. 中华医学杂志, 2018, 98(20): 1544-1548.
21.	Li H, Xie R, Wang Y, et al. A new scale for the evaluation of clinical practice guidelines applicability: development and appraisal. Implement Sci, 2018, 13(1): 61-70.

1. The ADAPTE collaboration. The apapte process: resource toolkit for guideline adaptation, version 2.0. Available from: http://www.g-i-n.net/working-groups/adaptation.
2. 曾力楠, 李幼平, 张伶俐, 等. 国内外制订临床指南的指南的循证评价. 中国循证医学杂志, 2016, 16(11): 1322-1330.
3. Shiffman RN, Dixon J, Brandt C, et al. The guideline implementability appraisal (GLIA): development of an instrument to identify obstacles to guideline implementation. BMC Med Inform Decis Mak, 2005, 5(1): 23.
4. Gagliardi AR, Brouwers MC, Palda VA, et al. How can we improve guideline use? A conceptual framework of implementability. Implement Sci, 2011, 6(1): 26.
5. 中华中医药学会. 中医临床诊疗指南的临床应用评价指标体系(2012). Available from: http://www.doc88.com/p-3933713266369.html.
6. 李慧, 谢秀丽, 王洋洋, 等. 中医(中西医结合)临床实践指南制修订方法—实施与评价. 中华中医药杂志, 2016, 31(12): 5119-5123.
7. International Diabetes Federation (IDF) Clinical Guideline Task Force. Guide for guidelines: a guide for clinical guideline development. International Diabetes Federation, 2003. Available at: www.idf.org.
8. Agree Collaboration. Appraisal of guidelines for research and evaluation in Europe Ⅱ (AGREE Ⅱ) instrument. Available from: http://www.agreetrust.org/.
9. World Health Organization. WHO handbook for guideline development. Available from: http://www.who.int/about/licensing/copyright_form/en/index.htmluk.
10. ACCP Evidence-Based Guideline Development. A successful and transparent approach addressing conflict of interest, funding, and patient-centered recommendations. Available from: http://journal.publications.chestnet.org/.
11. American College of Cardiology Foundation and American Heart Association (ACCF/AHA). Methodology manual and policies from the ACCF/AHA Task Force on Practice Guidelines. American College of Cardiology Foundation and American Heart Association Inc, 2010: 1-88.
12. Palda V A, Davis D, Goldman J. A guide to the Canadian medical association handbook on clinical practice guidelines. CAN MED ASSOC J, 2007, 177(10): 1221-1226.
13. BNSc for the Canadian Guideline Adaptation Study Group. Can-implement-guideline adaptation and implementation planning resource, 2012. Available from: http://www.cancerview.ca..
14. National Institute for Health and Care Excellence (NICE). The guidelines manual. National Institute for Health and Care Excellence, 2012.
15. Scottish Intercollegiate Guidelines Network (SIGN). SIGN 50: a guideline developer’s handbook. Available from: http://www.sign.ac.uk.
16. Schunemann HJ, Fretheim A, Oxman AD. Improving the use of research evidence in guideline development I. Guidelines for guidelines. Health Res Policy Syst, 2006, 4(13): 1-6.
17. European Region of the World Confederation for Physical Therapy. Framework for clinical guideline development in physiotherapy, 2004. Available from: http://www.guidelines-registry.cn/uploadfile/2016/0914/20160914032822587.pdf.
18. New Zealand Guideline Group. Handbook for the preparation of explicit evidence-based clinical practice guidelines. Available from: http://www.nzgg.org.nz/.
19. National Health and Medical Research Council (NHMRC). A guide to the development, implementation and evaluation of clinical practice guidelines. Available from: http://www.ausinfo.gov.au/general/gen_hottobuy.htm.
20. 王吉耀, 王小钦, 金雪娟, 等. 中国临床实践指南评价体系的制定与初步验证. 中华医学杂志, 2018, 98(20): 1544-1548.
21. Li H, Xie R, Wang Y, et al. A new scale for the evaluation of clinical practice guidelines applicability: development and appraisal. Implement Sci, 2018, 13(1): 61-70.

Chinese Journal of Evidence-Based Medicine

Global guideline clinical applicability evaluation tool: a systematic review

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content